<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD12070000_1</Organism_ID>
  <Organism>Klebsiella pneumoniae</Organism>
  <Organism_Latin>Klebsiella pneumoniae</Organism_Latin>
  <UniProt_ID>P0AD64</UniProt_ID>
  <Seq_Length>286</Seq_Length>
  <Molecule_Weight>31224</Molecule_Weight>
  <Catalytic_Mechanism>A beta-lactam + H(2)O = a substituted beta-amino acid.</Catalytic_Mechanism>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>2</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>PIT-2</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.</Detail>
      <Keyword>Hydrolase activity</Keyword>
      <Ontology_ID>GO:0016787</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: a beta-lactam + H2O = a substituted beta-amino acid.</Detail>
      <Keyword>Beta-lactamase activity</Keyword>
      <Ontology_ID>GO:0008800</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the breakdown of a beta-lactam antibiotic, any member of a class of natural or semisynthetic antibiotics whose characteristic feature is a strained, four-membered beta-lactam ring. They include the penicillins and many of the cephalosporins.</Detail>
      <Keyword>Beta-lactam antibiotic catabolic process</Keyword>
      <Ontology_ID>GO:0030655</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antibiotic stimulus. An antibiotic is a chemical substance produced by a microorganism which has the capacity to inhibit the growth of or to kill other microorganisms.</Detail>
      <Keyword>Response to antibiotic</Keyword>
      <Ontology_ID>GO:0046677</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <Molecule_Seq>
    <Protein_Seq>MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR</Protein_Seq>
  </Molecule_Seq>
  <Gene>
    <Gene_Name>bla</Gene_Name>
    <Gene_Alias>shv1</Gene_Alias>
    <Genbank_ACCN>NG_036025</Genbank_ACCN>
    <Protein_ACCN>YP_009079584</Protein_ACCN>
  </Gene>
  <PDB_List>
    <PDB>
      <PDB_Title>Complex of SHV S130G mutant beta-lactamase complexed to SA2-13</PDB_Title>
      <PDB_ID>3V50</PDB_ID>
      <Resolution>1.45</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3V50</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The importance of the trans-enamine intermediate as a beta-lactamase inhibition strategy  probed in inhibitor-resistant SHV beta-lactamase variants.</PubMed_Title>
      <Author>Ke, W., et al.</Author>
      <Journal>Chemmedchem(2012)7:1002-1008</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22438274?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the M69V E166A double mutant of SHV-1 b-lactamase complexed to tazobactam</PDB_Title>
      <PDB_ID>2H10</PDB_ID>
      <Resolution>1.75</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2H10</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Effect of the inhibitor-resistant M69V substitution on the structures and populations of trans-enamine beta-lactamase intermediates.</PubMed_Title>
      <Author>Totir, M.A., et al.</Author>
      <Journal>Biochemistry(2006)45:11895-11904</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17002290?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>ESBL R164S mutant of SHV-1 beta-lactamase complexed with SA2-13</PDB_Title>
      <PDB_ID>3OPP</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3OPP</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Ligand-dependent disorder of the Omega loop observed in extended-spectrum SHV-type beta-lactamase.</PubMed_Title>
      <Author>Sampson, J.M., et al.</Author>
      <Journal>Antimicrob.Agents Chemother.(2011)55:2303-2309</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21357298?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of Ser130Gly SHV-1 beta-lactamase</PDB_Title>
      <PDB_ID>1TDL</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1TDL</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Inhibitor-resistant class A beta-lactamases: consequences of the Ser130-to-Gly mutation seen in Apo and tazobactam structures of the SHV-1 variant</PubMed_Title>
      <Author>Sun, T., et al.</Author>
      <Journal>Biochemistry(2004)43:14111-14117</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15518561?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SHV-1 in complex with 4H-pyrazolo[1,5-c][1,3]thiazole containing penem inhibitor</PDB_Title>
      <PDB_ID>4GDB</PDB_ID>
      <Resolution>1.84</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4GDB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structures of SHV-1 beta-lactamase with penem and penam sulfone inhibitors that form cyclic intermediates stabilized by carbonyl conjugation</PubMed_Title>
      <Author>Ke, W., et al.</Author>
      <Journal>Plos One(2012)7:e49035-e49035</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/23145056?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Complex of S130G SHV-1 beta-lactamase with tazobactam</PDB_Title>
      <PDB_ID>1TDG</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1TDG</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Inhibitor-resistant class A beta-lactamases: consequences of the Ser130-to-Gly mutation seen in Apo and tazobactam structures of the SHV-1 variant</PubMed_Title>
      <Author>Sun, T., et al.</Author>
      <Journal>Biochemistry(2004)43:14111-14117</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15518561?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>high-resolution structure of apo wt SHV-1 beta-lactamase</PDB_Title>
      <PDB_ID>4FH4</PDB_ID>
      <Resolution>1.09</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4FH4</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of a pre-acylation complex of the beta-lactamase inhibitor, sulbactam, bound to a sulfenamide bond containing thiol-beta-lactamase</PubMed_Title>
      <Author>Rodkey, E.A., et al.</Author>
      <Journal>J.Am.Chem.Soc.(2012)134:16798-16804</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22974281?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF SHV-1 BETA-LACTAMASE</PDB_Title>
      <PDB_ID>1SHV</PDB_ID>
      <Resolution>1.98</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1SHV</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of the SHV-1 beta-lactamase.</PubMed_Title>
      <Author>Kuzin, A.P., et al.</Author>
      <Journal>Biochemistry(1999)38:5720-5727</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10231522?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of SHV-1 beta-lactamase in complex with the 7-alkylidenecephalosporin DCM-1-10 at 1.14 Ang resolution</PDB_Title>
      <PDB_ID>4JPM</PDB_ID>
      <Resolution>1.14</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4JPM</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>beta-Lactamase Inhibition by 7-Alkylidenecephalosporin Sulfones: Allylic Transposition and Formation of an Unprecedented Stabilized Acyl-Enzyme.</PubMed_Title>
      <Author>Rodkey, E.A., et al.</Author>
      <Journal>J.Am.Chem.Soc.(2013)135:18358-18369</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/24219313?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of s70c beta-lactamase bound to sulbactam</PDB_Title>
      <PDB_ID>4FH2</PDB_ID>
      <Resolution>1.44</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4FH2</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of a pre-acylation complex of the beta-lactamase inhibitor, sulbactam, bound to a sulfenamide bond containing thiol-beta-lactamase</PubMed_Title>
      <Author>Rodkey, E.A., et al.</Author>
      <Journal>J.Am.Chem.Soc.(2012)134:16798-16804</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22974281?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the SHV-1 D104E beta-lactamase/beta-lactamase inhibitor protein (BLIP) complex</PDB_Title>
      <PDB_ID>3N4I</PDB_ID>
      <Resolution>1.56</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3N4I</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Specificity and Cooperativity at beta-lactamase Position 104 in TEM-1/BLIP and SHV-1/BLIP interactions</PubMed_Title>
      <Author>Hanes, M.S., et al.</Author>
      <Journal>Proteins(2011)79:1267-1276</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21294157?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Penam sulfone PSR-3-226 bound to E166A variant of SHV-1 beta-lactamase</PDB_Title>
      <PDB_ID>4MBH</PDB_ID>
      <Resolution>1.22</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4MBH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Penam sulfones and beta-lactamase inhibition: SA2-13 and the importance of the C2 side chain length and composition.</PubMed_Title>
      <Author>Rodkey, E.A., et al.</Author>
      <Journal>Plos One(2014)9:e85892-e85892</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/24454944?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of clavulanic acid bound to E166A variant of SHV-1 beta-lactamase</PDB_Title>
      <PDB_ID>2A49</PDB_ID>
      <Resolution>1.43</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2A49</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>High Resolution Crystal Structures of the trans-Enamine Intermediates Formed by Sulbactam and Clavulanic Acid and E166A SHV-1 {beta}-Lactamase.</PubMed_Title>
      <Author>Padayatti, P.S., et al.</Author>
      <Journal>J.Biol.Chem.(2005)280:34900-34907</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16055923?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>ESBL R164H mutant SHV-1 beta-lactamase</PDB_Title>
      <PDB_ID>3OPL</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3OPL</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Ligand-dependent disorder of the Omega loop observed in extended-spectrum SHV-type beta-lactamase.</PubMed_Title>
      <Author>Sampson, J.M., et al.</Author>
      <Journal>Antimicrob.Agents Chemother.(2011)55:2303-2309</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21357298?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>K234R: apo structure of inhibitor resistant beta-lactamase</PDB_Title>
      <PDB_ID>4FCF</PDB_ID>
      <Resolution>1.09</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4FCF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Design and exploration of novel boronic acid inhibitors reveals important interactions with a clavulanic acid-resistant sulfhydryl-variable (SHV) beta-lactamase.</PubMed_Title>
      <Author>Winkler, M.L., et al.</Author>
      <Journal>J.Med.Chem.(2013)56:1084-1097</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/23252553?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the M69V E166A double mutant of SHV-1 b-lactamase complexed to clavulanic acid</PDB_Title>
      <PDB_ID>2H0T</PDB_ID>
      <Resolution>1.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2H0T</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Effect of the inhibitor-resistant M69V substitution on the structures and populations of trans-enamine beta-lactamase intermediates.</PubMed_Title>
      <Author>Totir, M.A., et al.</Author>
      <Journal>Biochemistry(2006)45:11895-11904</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17002290?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SHV-1 beta-lactamase in complex with penam sulfone SA3-53</PDB_Title>
      <PDB_ID>4GD8</PDB_ID>
      <Resolution>1.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4GD8</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structures of SHV-1 beta-lactamase with penem and penam sulfone inhibitors that form cyclic intermediates stabilized by carbonyl conjugation</PubMed_Title>
      <Author>Ke, W., et al.</Author>
      <Journal>Plos One(2012)7:e49035-e49035</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/23145056?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of Penam sulfone PSR-4-157 bound to SHV-1 beta-lactamase</PDB_Title>
      <PDB_ID>4MBF</PDB_ID>
      <Resolution>1.54</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4MBF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Penam sulfones and beta-lactamase inhibition: SA2-13 and the importance of the C2 side chain length and composition.</PubMed_Title>
      <Author>Rodkey, E.A., et al.</Author>
      <Journal>Plos One(2014)9:e85892-e85892</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/24454944?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of the SHV D104K Beta-lactamase/Beta-lactamase inhibitor protein (BLIP) complex</PDB_Title>
      <PDB_ID>2G2W</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2G2W</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural and Computational Characterization of the SHV-1 beta-Lactamase-beta-Lactamase Inhibitor Protein Interface.</PubMed_Title>
      <Author>Reynolds, K.A., et al.</Author>
      <Journal>J.Biol.Chem.(2006)281:26745-26753</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16809340?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF SHV-1 BETA-LACTAMASE INHIBITED BY TAZOBACTAM</PDB_Title>
      <PDB_ID>1VM1</PDB_ID>
      <Resolution>2.02</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1VM1</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD12070001</ASD_Ligand>
      <PubMed_Title>Inhibition of the SHV-1 beta-lactamase by sulfones: crystallographic observation of two reaction intermediates with tazobactam.</PubMed_Title>
      <Author>Kuzin, A.P., et al.</Author>
      <Journal>Biochemistry(2001)40:1861-1866</Journal>
      <PubMed_ID>11327849</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SHV-1 class A beta-lactamase complexed with meropenem</PDB_Title>
      <PDB_ID>2ZD8</PDB_ID>
      <Resolution>1.05</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2ZD8</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Inhibition of class A beta-lactamases by carbapenems: crystallographic observation of two conformations of meropenem in SHV-1.</PubMed_Title>
      <Author>Nukaga, M., et al.</Author>
      <Journal>J.Am.Chem.Soc.(2008)130:12656-12662</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18761444?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SHV-1 beta-lactamase complex with compound 2</PDB_Title>
      <PDB_ID>3MXS</PDB_ID>
      <Resolution>1.24</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3MXS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Novel Insights into the Mode of Inhibition of Class A SHV-1 {beta}-Lactamases Revealed by Boronic Acid Transition State Inhibitors.</PubMed_Title>
      <Author>Ke, W., et al.</Author>
      <Journal>Antimicrob.Agents Chemother.(2011)55:174-183</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21041505?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SHV-1 beta-lactamase with a penem inhibitor</PDB_Title>
      <PDB_ID>1ONG</PDB_ID>
      <Resolution>1.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1ONG</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Inhibition of Class A and Class C Beta-Lactamases by Penems: Crystallographic Structures of a Novel 1,4-Thiazepine Intermediate</PubMed_Title>
      <Author>Nukaga, M., et al.</Author>
      <Journal>Biochemistry(2003)42:13152-13159</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/14609325?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SA2-13 penam sulfone complexed to wt SHV-1 beta-lactamase</PDB_Title>
      <PDB_ID>2H5S</PDB_ID>
      <Resolution>1.28</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2H5S</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Rational Design of a beta-Lactamase Inhibitor Achieved via Stabilization of the trans-Enamine Intermediate: 1.28 A Crystal Structure of wt SHV-1 Complex with a Penam Sulfone.</PubMed_Title>
      <Author>Padayatti, P.S., et al.</Author>
      <Journal>J.Am.Chem.Soc.(2006)128:13235-13242</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17017804?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of K234R inhibitor-resistant variant of SHV beta-lactamase in complex with SA2-13</PDB_Title>
      <PDB_ID>4MBK</PDB_ID>
      <Resolution>1.46</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4MBK</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Penam sulfones and beta-lactamase inhibition: SA2-13 and the importance of the C2 side chain length and composition.</PubMed_Title>
      <Author>Rodkey, E.A., et al.</Author>
      <Journal>Plos One(2014)9:e85892-e85892</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/24454944?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of M69V mutant of SHV beta-lactamase</PDB_Title>
      <PDB_ID>3V5M</PDB_ID>
      <Resolution>1.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3V5M</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The importance of the trans-enamine intermediate as a beta-lactamase inhibition strategy  probed in inhibitor-resistant SHV beta-lactamase variants.</PubMed_Title>
      <Author>Ke, W., et al.</Author>
      <Journal>Chemmedchem(2012)7:1002-1008</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22438274?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of apo S70C SHV beta-lactamase</PDB_Title>
      <PDB_ID>4FD8</PDB_ID>
      <Resolution>1.52</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4FD8</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of a pre-acylation complex of the beta-lactamase inhibitor, sulbactam, bound to a sulfenamide bond containing thiol-beta-lactamase</PubMed_Title>
      <Author>Rodkey, E.A., et al.</Author>
      <Journal>J.Am.Chem.Soc.(2012)134:16798-16804</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22974281?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of sulbactam bound to E166A variant of SHV-1 beta-lactamase</PDB_Title>
      <PDB_ID>2A3U</PDB_ID>
      <Resolution>1.34</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2A3U</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>High Resolution Crystal Structures of the trans-Enamine Intermediates Formed by Sulbactam and Clavulanic Acid and E166A SHV-1 {beta}-Lactamase.</PubMed_Title>
      <Author>Padayatti, P.S., et al.</Author>
      <Journal>J.Biol.Chem.(2005)280:34900-34907</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16055923?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of the SHV-1 Beta-lactamase/Beta-lactamase inhibitor protein (BLIP) E73M/S130K/S146M complex</PDB_Title>
      <PDB_ID>3C4O</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3C4O</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Computational redesign of the SHV-1 beta-lactamase/beta-lactamase inhibitor protein interface.</PubMed_Title>
      <Author>Reynolds, K.A., et al.</Author>
      <Journal>J.Mol.Biol.(2008)382:1265-1275</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18775544?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SHV-1 beta-lactamase complex with compound 1</PDB_Title>
      <PDB_ID>3MXR</PDB_ID>
      <Resolution>1.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3MXR</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Novel Insights into the Mode of Inhibition of Class A SHV-1 {beta}-Lactamases Revealed by Boronic Acid Transition State Inhibitors.</PubMed_Title>
      <Author>Ke, W., et al.</Author>
      <Journal>Antimicrob.Agents Chemother.(2011)55:174-183</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21041505?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>ESBL R164S mutant of SHV-1 beta-lactamase</PDB_Title>
      <PDB_ID>3OPH</PDB_ID>
      <Resolution>1.34</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3OPH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Ligand-dependent disorder of the Omega loop observed in extended-spectrum SHV-type beta-lactamase.</PubMed_Title>
      <Author>Sampson, J.M., et al.</Author>
      <Journal>Antimicrob.Agents Chemother.(2011)55:2303-2309</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21357298?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SHV-1 beta-lactamase in complex with penam sulfone SA1-204</PDB_Title>
      <PDB_ID>4GD6</PDB_ID>
      <Resolution>1.53</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4GD6</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structures of SHV-1 beta-lactamase with penem and penam sulfone inhibitors that form cyclic intermediates stabilized by carbonyl conjugation</PubMed_Title>
      <Author>Ke, W., et al.</Author>
      <Journal>Plos One(2012)7:e49035-e49035</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/23145056?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SHV-1 beta-lactamase complex with LN1-255</PDB_Title>
      <PDB_ID>3D4F</PDB_ID>
      <Resolution>1.55</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3D4F</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Strategic Design of an Effective {beta}-Lactamase Inhibitor: LN-1-255, A 6-ALKYLIDENE-2'-SUBSTITUTED PENICILLIN SULFONE</PubMed_Title>
      <Author>Pattanaik, P., et al.</Author>
      <Journal>J.Biol.Chem.(2009)284:945-953</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18955486?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of E166A mutant of SHV-1 beta-lactamase with the trans-enamine intermediate of tazobactam</PDB_Title>
      <PDB_ID>1RCJ</PDB_ID>
      <Resolution>1.63</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1RCJ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Tazobactam Forms a Stoichiometric trans-Enamine Intermediate in the E166A Variant of SHV-1 beta-Lactamase: 1.63 A Crystal Structure</PubMed_Title>
      <Author>Padayatti, P.S., et al.</Author>
      <Journal>Biochemistry(2004)43:843-848</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/14744126?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the M69V E166A double mutant of SHV-1 b-lactamase complexed to sulbactam</PDB_Title>
      <PDB_ID>2H0Y</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2H0Y</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Effect of the inhibitor-resistant M69V substitution on the structures and populations of trans-enamine beta-lactamase intermediates.</PubMed_Title>
      <Author>Totir, M.A., et al.</Author>
      <Journal>Biochemistry(2006)45:11895-11904</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17002290?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of the SHV-1 Beta-lactamase/Beta-lactamase inhibitor protein (BLIP) complex</PDB_Title>
      <PDB_ID>2G2U</PDB_ID>
      <Resolution>1.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2G2U</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural and Computational Characterization of the SHV-1 beta-Lactamase-beta-Lactamase Inhibitor Protein Interface.</PubMed_Title>
      <Author>Reynolds, K.A., et al.</Author>
      <Journal>J.Biol.Chem.(2006)281:26745-26753</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16809340?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of the SHV-1 Beta-lactamase/Beta-lactamase inhibitor protein (BLIP) E73M complex</PDB_Title>
      <PDB_ID>3C4P</PDB_ID>
      <Resolution>1.75</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3C4P</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Computational redesign of the SHV-1 beta-lactamase/beta-lactamase inhibitor protein interface.</PubMed_Title>
      <Author>Reynolds, K.A., et al.</Author>
      <Journal>J.Mol.Biol.(2008)382:1265-1275</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18775544?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SHV-1 beta-lactamase complex with LP06</PDB_Title>
      <PDB_ID>3MKE</PDB_ID>
      <Resolution>1.75</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3MKE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Novel Insights into the Mode of Inhibition of Class A SHV-1 {beta}-Lactamases Revealed by Boronic Acid Transition State Inhibitors.</PubMed_Title>
      <Author>Ke, W., et al.</Author>
      <Journal>Antimicrob.Agents Chemother.(2011)55:174-183</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21041505?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SHV-1 class A beta-lactamase complexed with penem WAY185229</PDB_Title>
      <PDB_ID>1Q2P</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Q2P</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure-activity relationship of 6-methylidene penems bearing tricyclic heterocycles as broad-spectrum beta-lactamase inhibitors: crystallographic structures show unexpected binding of 1,4-thiazepine intermediates</PubMed_Title>
      <Author>Venkatesan, A.M., et al.</Author>
      <Journal>J.Med.Chem.(2004)47:6556-6568</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15588091?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>ESBL R164H mutant of SHV-1 beta-lactamase complexed to SA2-13</PDB_Title>
      <PDB_ID>3OPR</PDB_ID>
      <Resolution>1.65</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3OPR</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Ligand-dependent disorder of the Omega loop observed in extended-spectrum SHV-type beta-lactamase.</PubMed_Title>
      <Author>Sampson, J.M., et al.</Author>
      <Journal>Antimicrob.Agents Chemother.(2011)55:2303-2309</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21357298?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SHV-1 beta-lactamase complex with GB0301</PDB_Title>
      <PDB_ID>3MKF</PDB_ID>
      <Resolution>1.33</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3MKF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Novel Insights into the Mode of Inhibition of Class A SHV-1 {beta}-Lactamases Revealed by Boronic Acid Transition State Inhibitors.</PubMed_Title>
      <Author>Ke, W., et al.</Author>
      <Journal>Antimicrob.Agents Chemother.(2011)55:174-183</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21041505?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <AllostericSite_List>
    <AllostericSite>
      <PDB_ID>1VM1</PDB_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>3.5.2.6</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC3/5/2/6.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD03940002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD12070001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2015-04-08</Create_Date>
</Organism_Record>